Home - Geneva Biotech

Geneva Biotech. Our Technology Platforms Insect Cells MammalianandPrimary Cells E.coli.

Read Geneva-biotech.com news digest here: view the latest Geneva Biotech articles and content updates right away or get to their most visited pages. Geneva-biotech.com is not yet rated by Alexa and its traffic estimate is unavailable. We haven’t detected security issues or inappropriate content on Geneva-biotech.com and thus you can safely use it. Geneva-biotech.com is hosted with CloudFlare, Inc. (United States) and its basic language is English.

  • Content verdict: Safe
  • Website availability: Live
  • English language flagLanguage: English
  • Last check:
  • N/A

    Visitors daily
  • N/A

    Pageviews daily
  • 4

    Google PR
  • N/A

    Alexa rank

Geneva-biotech.com news digest

  • 5 years

    T-Cell and B-Cell Transduction Technologies

    Geneva Biotech releases the first efficient non-lentiviral transduction system for immortal T-cells and B-cells. Please see Mammalian Product Category “T-Cells B-Cells”
    The post T-Cell and B-Cell Transduction Technologies appeared first on Geneva Biotech....

  • 5 years

    Leading baculoviral genomes

    Many of Geneva Biotech’s industry leading baculoviral genomes are now available as competent cells in Europe, Asia, and North America !
    The post Leading baculoviral genomes appeared first on Geneva Biotech.

  • 6 years

    Disruptive discovery method for inhibitors of protein-protein interactions

    Protein-Protein interactions (PPIs) are central to most essential cellular mechanisms including gene expression, protein translocation, cell cycle progression and signal transduction. Bellón-Echeverría et al. published in Scientific Reports a proof of...

  • 6 years

    13 Lab International Benchmarking Study Names EMBacY the World’s Best Baculoviru...

    Stolt-Bergner et al. published in Journal of Structural Biology a benchmarking initiative in 13 independent labs to compare the world’s leading baculovirus expression systems. Geneva Biotech’s EMBacY virus was ranked #1 in performance.
    The post 13 Lab International Benchmarking Study Names EMBacY the World’s Best Baculovirus appeared first on Geneva Biotech....

Domain history

Web host: CloudFlare, Inc.
Registrar: GoDaddy.com, LLC
Registrant: Registration Private (Domains By Proxy, LLC)
Updated: June 07, 2019
Expires: June 12, 2024
Created: June 12, 2012

Whois record

Safety scores

Trustworthiness

N/A

Child safety

N/A